Milner secures new Doctoral Training award through UK Functional Genomics Initiative
We are pleased to announce that the Functional Genomics Screening Laboratory (FGSL) is part of a new UK Human Functional Genomics Initiative Doctoral Landscape Award (FGx-DLA), for which applications are now open. The aim of the FGx-DLA is to equip the next generation...
Milner welcomes Department for Business, Innovation, Science and Trade to Cambridge Biomedical Campus
The Milner Therapeutics Institute was delighted to welcome Isobel Stephen and Marguerite Meyer Bassnett from the Department for Business, Innovation, Science and Trade to the Institute. Dr Cathy Tralau-Stewart, Executive Director of the Milner Therapeutics Institute,...
Milner Therapeutics Institute supports new £20 million MRC Hub to accelerate next-generation drug discovery
The Milner Therapeutics Institute (MTI) is proud to be part of a new £20 million Medical Research Council (MRC) investment that will establish a UK Pre-clinical Translational Models Hub. Led by Professor Matthias Zilbauer and Professor Bertie Göttgens of the Cambridge...
Milner Bio-incubator company Healthspan Biotics rebrands as OneCarbon
We are delighted to announce that one of our Bio-incubator companies, Healthspan Biotics, has rebranded to OneCarbon. The new name reflects the company’s pioneering research into one-carbon metabolism and marks the next chapter in its mission to develop...